Recall initiated following suspension of market authorisation by Health Canada. The oral use by self medicating of the mother tincture ingredient Dryopteris filix-mas in the homeopathic product should not be authorised on the Canadian market due to unfavourable risks:benefits ratio and the fact that a "safe" dosage of Male fern cannot be determined.